Neurodegenerative disease research
Clinical studies at Helse Stavanger HF focus on Alzheimer’s disease and mild cognitive impairment, with interest in treatments aimed at preserving memory and slowing cognitive decline in early-stage disease.
- Early Alzheimer’s disease
- Mild cognitive impairment
- Memory preservation
- Biomarkers of neurodegeneration
Research activity also includes exosome biomarkers and measures linked to cell death in cognitive disorders.
Pediatric respiratory research
The sponsor is involved in studies of chronic wet cough in young children, with attention to symptom resolution, relapse, and longer-term respiratory outcomes.
- Chronic wet cough
- Pediatric airway disease
- Symptom relapse
- Long-term respiratory outcomes
These trials examine treatment response alongside airway microbiome and gut microbiome factors.
Infection and inflammatory mechanisms
Work in children with respiratory symptoms includes interest in antibiotic treatment, inflammation, and the biological factors that may influence recovery and recurrence.
- Antibiotic efficacy
- Inflammatory pathways
- Microbiome interactions
- Genetic influences
Genetic and microbial correlates are studied alongside clinical outcomes in pediatric respiratory illness.
Translational biomarker research
The trial portfolio includes biomarker-focused work spanning neurodegenerative disease and pediatric infection-related conditions, reflecting interest in measurable biological signals linked to disease activity and treatment response.
- Exosome biomarkers
- Cell death markers
- Microbiome signatures
- Clinical response indicators
These areas connect clinical neurology and respiratory medicine through shared attention to disease mechanisms.
